Skip Navigation LinksHome > January 2013 - Volume 20 - Issue 1 > Linear EBUS in Staging Non–Small Cell Lung Cancer and Diagno...
Journal of Bronchology & Interventional Pulmonology:
doi: 10.1097/LBR.0b013e31827d1514
Review Article

Linear EBUS in Staging Non–Small Cell Lung Cancer and Diagnosing Benign Diseases

Dincer, H. Erhan MD, FCCP

Collapse Box


As an evolving technique, linear endobronchial ultrasound is becoming the first choice and standard of care not only to diagnose the malignant and benign mediastinal lesions but also to stage non–small cell lung cancer. Lung cancer is the leading cause of cancer-related mortality in both men and women. The disease causes more death compared with colorectal, breast, and prostate cancers combined in the United States. Staging of lung cancer determines the prognosis. The type of lung cancer has changed in the past few decades. The frequency of adenocarcinoma has increased, whereas squamous cell carcinoma now is less frequent. Determining the cell type and its molecular characteristics allow targeted treatments in adenocarcinoma. The diagnosis of indeterminate mediastinal lymph nodes or masses and staging lung cancer might be challenging. This article will review the principles and clinical utility of endobronchial ultrasound in mediastinal lesions.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.